[ Price : $8.95]
Sanofi-Aventis and Regeneron say they are terminating a Phase 3 study of aflibercept plus gemcitabine in treating metastatic pancr...[ Price : $8.95]
Discovery Laboratories will present a limited clinical trial proposal to FDA 9/29 in an effort to move its Surfaxin NDA forward.[ Price : $8.95]
Eli Lilly says it will pay for Chicago Bears quarterback Jay Cutlers touchdown passes and pass completions to help fund scholarshi...[ Price : $8.95]
FDA releases new details about when Warning Letter close-out letters can be issued as part of commissioner Margaret Hamburgs new e...[ Price : $8.95]
FDA accepts for review a Merz Pharmaceuticals PMA for Belotero Balance, a hyaluronic acid-based monophasic gel dermal filler.[ Price : $8.95]
FDA says that Covidien has recalled lots of its Pedi-Cap CO2 detector due to a problem that could lead to serious adverse health c...[ Price : $8.95]
FDA classifies ConMeds recall of handpieces and cables as Class 1.[ Price : $8.95]
QuatRx says it will submit an NDA to FDA early next year for its Ophena treatment for vaginal symptoms associated with menopause.